market-trends is the sole category represented across all 1 tracked stories. Zevia PBC is most often covered alongside Chemed Corporation, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 4 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Zevia PBC
market-trends is the sole category represented across all 1 tracked stories. Zevia PBC is most often covered alongside Chemed Corporation, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 4 across the same-window beat baseline. Their average consequence score of 5 runs below the beat's 5.7 for that window. Zevia PBC appears in 1 tracked Healthcare story from February 25, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 31 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Zevia PBC. Shared-story counts are live from our verified record — not editorial picks.
Chemed Corporation and Zevia PBC both reported fourth-quarter 2025 revenue figures that fell short of Wall Street expectations, triggering significant stock price declines. Chemed, a major player in the hospice care sector through VITAS, saw its shares plummet 14.7% as investors reacted to the top-line disappointment.